Soetjipto

TL;DR: The present results suggest that glycycoumarin, glycyrin, Glycyrol and liquiritigenin isolated from G. uralensis, as well as isoliquiritigin, licochalcone A and glabridin, would be good candidates for seed compounds to develop antivirals against HCV.

TL;DR: Two novel HBV subgenotypes are proposed, HBV/C6 andHBV/D6, the first of which is the most prevalent subgenotype of HBV in Papua, Indonesia, possibly representing a unique antigenic group (provisionally referred to as adrq indeterminate).

TL;DR: Indonesian medicinal plants derived from 17 species of medicinal plants explored in the East Java region showed antiviral activities against all the HCV genotypes tested with the exception that some genotype(s) showed significant resistance to FFL and to MMS to a lesser extent.

TL;DR: It is reported here that all HBV isolates tested in Surabaya belonged to genotype B, with more than 90% of them being classified into subtype adw, and HBsAg titers were lower in HBV carriers with HCV co‐infection than in those withoutHCV co-infection.

TL;DR: Mode-of-action analyses revealed that chalepin and pseudane IX inhibited HCV at the post-entry step and decreased the levels of HCV RNA replication and viral protein synthesis.